You hear a lot these days about how so few cases go to trial—the “Death of the American trial,” some have called it. But don’t tell that to James Hurst.

The Kirkland & Ellis partner just won his second major jury trial in three weeks, successfully defending Alere (now owned by Abbott Laboratories)  in a patent fight over its best-selling urine drug screening test, the iCup.